Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.
about
Mutant alpha-actinin-4 promotes tumorigenicity and regulates cell motility of a human lung carcinomaAlpha E beta 7 integrin interaction with E-cadherin promotes antitumor CTL activity by triggering lytic granule polarization and exocytosisFunctional and molecular characterization of a KIR3DL2/p140 expressing tumor-specific cytotoxic T lymphocyte clone infiltrating a human lung carcinomaProteomic analysis of exosomes secreted by human mesothelioma cells.Induction of higher-avidity human CTLs by vector-mediated enhanced costimulation of antigen-presenting cells.The many important facets of T-cell repertoire diversity.Multiple costimulatory modalities enhance CTL avidity.Elevated tumor-associated antigen expression suppresses variant peptide vaccine responses.Gene transfer of tumor-reactive TCR confers both high avidity and tumor reactivity to nonreactive peripheral blood mononuclear cells and tumor-infiltrating lymphocytes.Reverse immunology approach for the identification of CD8 T-cell-defined antigens: advantages and hurdles.Expression of co-stimulator 4-1BB molecule in hepatocellular carcinoma and adjacent non-tumor liver tissue, and its possible role in tumor immunityRoadmap to a better therapeutic tumor vaccine.Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathwayIn vivo modulation of avidity in highly sensitive CD8(+) effector T cells following viral infectionImmune Signature of Enhanced Functional Avidity CD8+ T Cells in vivo Induced by Vaccinia Vectored Vaccine.Peptide-MHC multimer-based monitoring of CD8 T-cells in HIV-1 infection and AIDS vaccine development.Current status and recent advances of next generation sequencing techniques in immunological repertoire.Chronic myelogenous leukemia shapes host immunity by selective deletion of high-avidity leukemia-specific T cells.Integrating the quality of the cytotoxic response and tumor susceptibility into the design of protective vaccines in tumor immunotherapy.Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors.Identification of a public CDR3 motif and a biased utilization of T-cell receptor V beta and J beta chains in HLA-A2/Melan-A-specific T-cell clonotypes of melanoma patients.Increased sensitivity to antigen in high avidity CD8(+) T cells results from augmented membrane proximal T-cell receptor signal transduction.Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy.Lentiviral calnexin-modified dendritic cells promote expansion of high-avidity effector T cells with central memory phenotype.
P2860
Q24321856-50EEF9E9-61B8-4E51-B424-08E79D554160Q24679720-0D8EDE9E-0B50-44D1-AD7F-9A43B06C8287Q28210382-5914223C-1DA2-4AD9-91E7-8D7E68C2A596Q31052352-3BE106E6-0642-496C-BAC5-B52714BF03D5Q34312794-516FD767-F834-4FE3-AAF7-319F39A97E84Q35709655-1F64D91A-2330-45BC-8525-7679DEFA7D31Q35901490-66A288ED-8AC0-467E-BF60-06C8287C4CEFQ35906719-542CCA58-10BF-4D92-94E5-0C39C7D2207EQ36327157-F4727052-9CFA-47C0-A13C-CD042DB656E4Q36471831-2A971A47-2CB2-4B87-922E-9866C28AB7A7Q36474377-AB4BA969-9ACC-44CC-B179-08620B789263Q36684496-E16B9531-AAAA-435A-9344-37AE969287E3Q36786880-CA0672FE-17E6-4EE3-A9AB-4B1FC3E830AEQ37231728-8A921F50-A238-4E4A-85FB-0C8DAA4EE92AQ37623153-2C500874-27D3-49D4-AF64-E2DBA3A9EBA3Q38265356-50FF7620-B0D5-4D61-84CA-CA6BC522F5C3Q38768307-36AABC3A-0437-4B7C-B4A1-235590A4A629Q39741064-32F68481-A0FC-4AE8-A7D4-33CFA6BB1B6AQ39741122-9F1A6261-F918-4B1F-B3CD-1E81B562EFADQ40375567-DB4D81A4-B5F2-4176-B00E-157A468FC620Q43147458-D0FAE784-6CF7-4C97-9664-222FD5413CFAQ45383664-F66554EC-A8BF-4629-A545-39B2A3A58FD9Q49432766-B79E907D-9C29-464A-AD7C-A26808CC128EQ51891004-546E3287-B47A-4BD4-B595-BB67E4A2C796
P2860
Cytotoxic T lymphocytes directed against a tumor-specific mutated antigen display similar HLA tetramer binding but distinct functional avidity and tissue distribution.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@ast
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@en
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@nl
type
label
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@ast
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@en
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@nl
prefLabel
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@ast
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@en
Cytotoxic T lymphocytes direct ...... idity and tissue distribution.
@nl
P2093
P2860
P356
P1476
Cytotoxic T lymphocytes direct ...... vidity and tissue distribution
@en
P2093
Fathia Mami-Chouaib
Hamid Echchakir
Isabelle Vergnon
Jeanne Menez
Salem Chouaib
P2860
P304
P356
10.1073/PNAS.142308199
P407
P577
2002-07-01T00:00:00Z